Finance

Lists
Why is ECOR down 2.08%?
Dive Deeper
ECOR:NASDAQ
electroCore, Inc.
$10.10
-2.08%
(-0.21) 1D
Oct 2, 2:14:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ECOR...
Open
$10.47
High
$11.02
Low
$10.01
Mkt. cap
91.02M
Avg. vol.
86.52K
Volume
88.68K
52-wk high
$12.70
52-wk low
$4.41
EPS
-$1.66
Beta
1.05
Shares outstanding
9.02M
No. of employees
83
Open
$10.47
High
$11.02
Low
$10.01
Mkt. cap
91.02M
Avg. vol.
86.52K
Volume
88.68K
52-wk high
$12.70
52-wk low
$4.41
EPS
-$1.66
Beta
1.05
Shares outstanding
9.02M
No. of employees
83
News stories
From web sources and news partners
Profile
electroCore, Inc. is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation. Wikipedia
About electroCore, Inc.
CEO-
Employees83
Founded2005
HeadquartersRockaway, New Jersey, United States
SectorMedical device
Websiteelectrocore.com
Analyst ratings
Based on 2 analysts giving stock ratings to ECOR in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ECOR in the last 3 months.
Highest
Current $10.10
$18.00 (+78.22%)
Average
$15.00 (+48.51%)
Lowest
$12.00 (+18.81%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Keller
H.C. Wainwright
Buy
Reiterated
$18.00
+78.2%
09/21/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$18.00
+78.2%
08/10/2026
Anthony Vendetti
Maxim Group
Buy
Reiterated
$12.00
+18.8%
08/07/2026
Ben Davis
RBC Capital
Buy
Reiterated
£185.00
+1,731.7%
06/15/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Reiterated
$19.85
+96.5%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
8.69M
9.24M
9.58M
9.45M
Cost of goods sold
1.22M
1.07M
1.22M
1.27M
Cost of revenue
1.22M
1.07M
1.22M
1.27M
Research and development expenses
662.00K
920.00K
740.00K
818.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.69M
10.19M
12.94M
10.13M
Operating expense
10.35M
11.11M
13.68M
10.95M
Total operating expenses
11.57M
12.18M
14.90M
12.22M
Operating income
-2.88M
-2.94M
-5.32M
-2.77M
Other non operating income
-375.00K
714.00K
-10.00K
-6.00K
EBT including unusual items
-3.40M
-2.98M
-5.59M
-3.06M
EBT excluding unusual items
-3.40M
-2.47M
-5.59M
-3.06M
Income tax expense
-
51.00K
-321.00K
-
Effective tax rate
-
-1.71%
5.74%
-
Other operating expenses
-
-
-
-
Net income
-3.40M
-3.04M
-5.27M
-3.06M
Net profit margin
-39.19%
-32.84%
-55.00%
-32.37%
Earnings per share
-
-
-
-
Interest and investment income
62.00K
85.00K
52.00K
40.00K
Interest expense
-208.00K
-324.00K
-318.00K
-321.00K
Net interest expenses
-146.00K
-239.00K
-266.00K
-281.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.77M
-2.83M
-5.30M
-2.77M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps